Intranasal Glucagon: A Promising Approach for Treatment of Severe Hypoglycemia
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Prevention of diabetic complications is mainly obtained through optimal control of blood glucose levels. With hypoglycemic drugs like beta-cell stimulating drugs and especially insulin, the limit to treatment is represented by hypoglycemia, a life-threatening occurrence that is dangerous itself and can induce fear of other episodes. Glucagon, injected subcutaneously (SC) or intramuscularly (IM), is the treatment of choice for severe hypoglycemia outside of the hospital setting. However, due to practical aspects such as preparation of solutions for administration and injection by untrained persons, there are obstacles to its routine use. This review focuses on the current status of alternative routes of administration of peptide hormones, and in particular the intranasal (IN) route of glucagon, as a promising approach for the treatment of severe hypoglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., et al. (2003) · Nature Medicine · doi:10.1038/nm919 · Cited by 851
Heni, M., Wagner, R., Kullmann, S., Veit, R., Mat Husin, H., Linder, K., Benkendorff, C., Peter, A., Stefan, N., Häring, H.-U., et al. (2014) · Diabetes · doi:10.2337/db14-0477 · Cited by 167
Hypoglycemia in Diabetes: Pathophysiology, Prevalence, and Prevention
Cryer, P. (2016) · doi:10.2337/9781580406499 · Cited by 104
FREYCHET, L. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92181-2 · Cited by 67
Research works printed but not linked: 35
- 10.1210/jc.2012-1561 · DOI · Paper page
- 10.2165/00003088-198917050-00001 · DOI
- 10.1136/bmj.284.6312.303 · DOI
- 10.1016/S0169-409X(97)00062-8 · DOI
- Reynolds JEF, 1996, The Extra Pharmacopoeia
- 10.1023/A:1018997625726 · DOI
- 10.1023/A:1018992716621 · doi:10.1023/a:1018992716621
- 10.1016/S8756-3282(95)00262-6 · DOI
- 10.2337/dc13-0690 · DOI
- 10.1016/j.jconrel.2010.08.004 · DOI
- 10.1016/j.peptides.2008.09.026 · DOI
- 10.1016/j.ijpharm.2009.07.022 · DOI
- 10.1016/j.ijpharm.2009.12.060 · doi:10.1016/j.ijpharm.2009.12.060
- 10.1111/j.1749-6632.2010.05799.x · DOI · Paper page
- 10.2337/db10-1360 · DOI · Paper page
- 10.1124/jpet.103.063222 · DOI
- 10.1002/pdi.138 · DOI · Paper page
- 10.1002/pdi.1960140204 · DOI
- 10.1136/bmj.287.6390.462-a · DOI
- 10.1007/BF02590783 · DOI
- 10.1007/BF00558516 · DOI
- 10.1007/BF00400568 · DOI
- 10.1016/S0378-5173(01)00930-9 · DOI
- 10.2337/diacare.12.9.604 · DOI
- 10.1007/BF00401209 · DOI
- 10.1016/0168-8227(92)90042-P · DOI
- 10.1007/BF02374475 · DOI
- 10.1007/BF00195909 · DOI
- 10.1111/j.1365-2125.1992.tb05660.x · DOI
- 10.1016/j.molmet.2014.01.006 · DOI
- Riber D, 2013, Diabetes, 62, 404-P
- Newswanger B, 2013, Diabetes, 62, 402-P
- 10.1089/dia.2014.0047 · DOI
- 10.3109/10903127.2012.717171 · DOI
- Sicard E, A single site, randomized, four-way, four-period PK/PD crossover phase I clinical study in 16 fasted healthy adult volunteers receiving 3 dose levels of intranasally administered glucagon and one dose level of glucagon administered by subcutaneous injection
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Samson, S. L., Vellanki, P., Blonde, L., Christofides, E. A., Galindo, R. J., Hirsch, I. B., Isaacs, S. D., Izuora, K. E., Low Wang, C. C., Twining, C. L., et al. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.02.001 · Cited by 375
Yale, J.-F., Dulude, H., Egeth, M., Piché, C. A., Lafontaine, M., Carballo, D., Margolies, R., Dissinger, E., Shames, A. R., Kaplowitz, N., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0460 · Cited by 88
Novel preparations of glucagon for the prevention and treatment of hypoglycemia
Hawkes, C. P., De Leon, D. D., & Rickels, M. R. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1216-4 · Cited by 46
Suico, J. G., Hövelmann, U., Zhang, S., Shen, T., Bergman, B., Sherr, J., Zijlstra, E., Frier, B. M., & Plum-Mörschel, L. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00845-7 · Cited by 32
Metadata
- Authors
- Pontiroli, A. E.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2014-11-10
- Volume
- 9
- Issue
- 1
- Pages
- 38-43
- ISSN
- 1932-2968 (ISSN-L)
- OpenAlex
- W1978425428
- Cited by
- 39
- References
- 4
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intranasal Glucagon: A Promising Approach for Treatment of Severe Hypoglycemia. https://app.cochat.ai/papers/10.1177/1932296814557518
- The paper
- Pontiroli, A. E. (2015). Intranasal Glucagon: A Promising Approach for Treatment of Severe Hypoglycemia. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296814557518
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.